Moberg Pharma AB (publ)
F:MB8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Moberg Pharma AB (publ)
F:MB8
|
SE |
|
Abeona Therapeutics Inc
NASDAQ:ABEO
|
US |
|
D
|
Dave and Buster's Entertainment, Inc
F:9DB
|
US |
Shareholder Yield
Current shareholder yield for
MB8 is
.
Peers Comparison
Shareholder Yield
Price Appreciation
MB8 Price
Moberg Pharma AB (publ)
| Average Annual Return | -16.38% |
| Standard Deviation of Annual Returns | 32.69% |
| Max Drawdown | -92% |
| Market Capitalization | 516.2m EUR |
| Shares Outstanding | 48 710 000 |
| Percentage of Shares Shorted |
N/A
|
MB8 Return Decomposition
Main factors of price return
Stock Splits
MB8's latest stock split occurred on May 24, 2023
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
Before the split, MB8 traded at 0.1132 per share. Afterward, the share price was about 1.3342.
The adjusted shares began trading on May 24, 2023. This was the only stock split in MB8's history.